Concentra Group Holdings Parent, Inc. (CON) FY2025 10-K Annual Report
Concentra Group Holdings Parent, Inc. (CON) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 26, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
Concentra Group Holdings Parent, Inc. FY2025 10-K Analysis
Business Overview
- • Core business: largest U.S. provider of occupational health services via 628 centers in 41 states, plus 411 onsite clinics in 44 states
- • New emphasis: completed IPO July 2024 raising $516.5M net; separated from Select Medical via spin-off November 2024
- • Strategic shift: transitioned from subsidiary within Select to independent public company; reverse stock split 1-for-4.295 in June 2024
- • Notable metric: revenue grew 14% to $2.16B in 2025, employees not specified but support functions transitioned via TSAs post-IPO
- • Unique fact: became large accelerated filer in 2026 due to public float exceeding $700M and now subject to Section 404(b) auditor attestation requirements
Management Discussion & Analysis
- • Revenue $2,163.4M, up 13.9% YoY from $1,900.2M driven by acquisitions and organic patient visit growth
- • Operating margin 15.4% vs 16.0% in prior year; net income margin 7.7% vs 8.8%; interest expense increased to $109.3M from $47.7M
- • Best performing segment: occupational health centers, comprising 93% revenue in 2025; onsite health clinics fastest growth from 3% to 5% revenue share
- • Repurchased 1.1M shares for $22.4M; voluntary debt repayment of $85M; capital expenditures increased depreciation to $75.8M from $67.2M
- • Management notes increased reimbursement rates and patient volume for 2026; risks include regulatory changes and integration of acquisitions
Risk Factors
- • Regulatory/legal risk: Non-compliance with Credit Agreement leverage covenant could trigger default, accelerate $942.9M Term Loan due 2031, and restrict borrowings under $450M Revolving Credit Facility
- • Macroeconomic threat: Inflation-driven labor cost increases in healthcare sector may pressure margins, though impact to date reported as not material
- • Operational risk: Integration complexity and cash outflow risk from $333.3M acquisitions of Nova and Pivot Onsite Innovations in 2025
- • Competitive risk: Expansion via strategic acquisitions of occupational health centers and onsite clinics crucial versus competitors in fragmented market
- • Financial risk: High leverage with $942.9M Term Loan (interest rate 5.72%) plus $650M Senior Notes at 6.875%, with scheduled principal payments of $10.7M next 12 months
Concentra Group Holdings Parent, Inc. FY2025 Key Financial MetricsXBRL
Revenue
$2.2B
▲ +13.9% YoY
Net Income
$166M
▼ -0.1% YoY
Operating Margin
15.4%
▼ -60bp YoY
Net Margin
7.7%
▼ -107bp YoY
ROE
42.3%
▼ -1810bp YoY
Total Assets
$2.9B
▲ +13.4% YoY
EPS (Diluted)
$1.30
▼ -11.0% YoY
Operating Cash Flow
$279M
▲ +1.7% YoY
Source: XBRL data from Concentra Group Holdings Parent, Inc. FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on Concentra Group Holdings Parent, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.